Suppr超能文献

肝细胞癌伴门静脉癌栓的新分类。

A new classification for hepatocellular carcinoma with portal vein tumor thrombus.

机构信息

Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University, 225 Changhai Road, Shanghai, People's Republic of China.

出版信息

J Hepatobiliary Pancreat Sci. 2011 Jan;18(1):74-80. doi: 10.1007/s00534-010-0314-0.

Abstract

BACKGROUND/PURPOSE: We aimed to correlate the survival of patients with hepatocellular carcinoma (HCC) with macroscopic portal vein tumor thrombus (PVTT) who underwent partial hepatectomy with or without portal thrombectomy with our PVTT classification. Currently, different staging systems for HCC are widely used in clinical practice. However, they lack the refinement in giving prognosis and guiding surgical treatment once macroscopic PVTT is present.

METHODS

A retrospective study was carried out, in a single tertiary center, from January 2001 to December 2004 on 441 patients who underwent partial hepatectomy with or without portal thrombectomy for HCC with macroscopic PVTT. Overall survival was examined to determine whether it was correlated with our PVTT classification, and with the TNM staging, Cancer of the Liver Italian Program (CLIP) scoring system, and the Japan Integrated Staging (JIS) scoring system.

RESULTS

With our PVTT classification, the numbers (percentages) of patients with types I, II, III, and IV PVTT were 144 (32.7%), 189 (42.9%), 86 (19.5%), and 22 (5.0%), respectively. The corresponding 1-, 2-, and 3-year overall survival rates for types I to IV PVTT were 54.8, 33.9, and 26.7%; 36.4, 24.9, and 16.9%; 25.9, 12.9, and 3.7%; and 11.1, 0, and 0%, respectively (log-rank of the survival curves P < 0.0001). Using the TNM system, the majority of patients were classified as stage III (n = 379 or 85.9%). Similarly, the majority of patients (n = 388 or 88.0%) were classified as having CLIP scores of 2 (n = 143, or 32.4%), 3 (n = 171, or 38.8%), and 4 (n = 74, or 16.8%). The 1-, 2-, and 3-year overall survivals for these 3 CLIP scores were very similar. Using the JIS score, the majority of patients (n = 372 or 84.4%) were classified with a JIS score of 2. The 1-, 2-, and 3-year overall survivals of patients with a JIS score of 2 were worse than those of the patients with a JIS score of 1 (this was expected) as well as being worse than those with a JIS score of 3 (this was unexpected). Thus, the latter 3 systems of classification were not refined enough, and they were inadequate for stratifying HCC with macroscopic PVTT treated with partial hepatectomy with or without thrombectomy.

CONCLUSIONS

In patients with HCC with macroscopic PVTT treated by partial hepatectomy with or without thrombectomy, our PVTT classification better stratified and predicted prognosis than the TNM staging, CLIP scoring system, and JIS scoring system, which were unrefined and inadequate for this group of patients.

摘要

背景/目的:我们旨在通过我们的门静脉癌栓(PVTT)分类,将接受或不接受门静脉血栓切除术的肝癌(HCC)患者的生存与宏观门静脉癌栓相关联。目前,不同的 HCC 分期系统在临床实践中被广泛应用。然而,一旦存在宏观 PVTT,它们在预后和指导手术治疗方面缺乏细化。

方法

在 2001 年 1 月至 2004 年 12 月期间,我们在一家单一的三级中心对 441 例接受了伴有或不伴有门静脉血栓切除术的 HCC 伴宏观 PVTT 的患者进行了回顾性研究。通过总体生存来确定其是否与我们的 PVTT 分类相关,以及与 TNM 分期、癌症意大利计划(CLIP)评分系统和日本综合分期(JIS)评分系统相关。

结果

根据我们的 PVTT 分类,I、II、III 和 IV 型 PVTT 的患者数量(百分比)分别为 144(32.7%)、189(42.9%)、86(19.5%)和 22(5.0%)。相应的 I、II、III 和 IV 型 PVTT 的 1、2 和 3 年总生存率分别为 54.8%、33.9%和 26.7%;36.4%、24.9%和 16.9%;25.9%、12.9%和 3.7%;11.1%、0%和 0%(生存曲线的对数秩检验 P <0.0001)。使用 TNM 系统,大多数患者被分类为 III 期(n=379 或 85.9%)。同样,大多数患者(n=388 或 88.0%)被分类为 CLIP 评分 2(n=143,或 32.4%)、3(n=171,或 38.8%)和 4(n=74,或 16.8%)。这些 3 个 CLIP 评分的 1、2 和 3 年总生存率非常相似。使用 JIS 评分,大多数患者(n=372 或 84.4%)被分类为 JIS 评分 2。JIS 评分 2 的患者的 1、2 和 3 年总生存率比 JIS 评分 1 的患者差(这是意料之中的),比 JIS 评分 3 的患者差(这是出乎意料的)。因此,后 3 种分类系统不够细化,不足以对接受伴或不伴血栓切除术的部分肝切除术治疗的伴有宏观 PVTT 的 HCC 进行分层。

结论

在接受伴或不伴血栓切除术的部分肝切除术治疗的 HCC 伴宏观 PVTT 的患者中,我们的 PVTT 分类比 TNM 分期、CLIP 评分系统和 JIS 评分系统更好地分层和预测预后,后 3 种系统在这组患者中不够细化,也不够充分。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验